腫瘤科
中性粒細胞減少症的管理
中文繁體(國語)
中性粒細胞減少症的管理
/assets/ct/fa815d8e9f/images/syn_placeholder_sqr.png

腫瘤科

中性粒細胞減少症的管理

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. (開啟新視窗)

Aapro MS, Bohlius J, Cameron DA, Dal Lago L, Donnelly JP, Kearney N, Lyman GH, Pettengell R, Tjan-Heijnen VC, Walewski J, Weber DC, Zielinski C; European Organisation for Research and Treatment of Cancer.

來源‎: Eur J Cancer 2011;47(1):8-32.

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. (開啟新視窗)

Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR; Infectious Diseases Society of America.

來源‎: Clin Infect Dis 2011;52(4):427-31.

High-dose chemotherapy without transfusion for Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in two Jehovah's Witnesses patients: a feasible option in the age of hematopoietic growth factors. (開啟新視窗)

Perol L, Grignano E, Contejean A, Gastaud L, Legoff M, Franchi P, Deau-Fischer B, Willems L, Bouscary D, Tamburini J

來源‎: Leuk Lymphoma. 2019;60(9):2324-7.

Recommendations for the use of WBC growth factors: American Society of Clinical Oncology Clinical Practice Guideline Update. (開啟新視窗)

Smith TJ, Bohlke K, Lyman GH, Carson KR, Crawford J, Cross SJ, Goldberg JM, Khatcheressian JL, Leighl NB, Perkins CL, Somlo G, Wade JL, Wozniak AJ, Armitage JO; American Society of Clinical Oncology.

來源‎: J Clin Oncol 2015;33(28):3199-212.